APA (7th ed.) Citation

Böhm, M., Butler, J., Krawczyk, M., Mahfoud, F., Haring, B., Filippatos, G., . . . Anker, S. D. (2023). Liver tests, cardiovascular outcomes and effects of empagliflozin in patients with heart failure and preserved ejection fraction: The EMPEROR-Preserved trial: research article. European journal of heart failure, 25(8), . https://doi.org/10.1002/ejhf.2922

Chicago Style (17th ed.) Citation

Böhm, Michael, et al. "Liver Tests, Cardiovascular Outcomes and Effects of Empagliflozin in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial: Research Article." European Journal of Heart Failure 25, no. 8 (2023). https://doi.org/10.1002/ejhf.2922.

MLA (9th ed.) Citation

Böhm, Michael, et al. "Liver Tests, Cardiovascular Outcomes and Effects of Empagliflozin in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial: Research Article." European Journal of Heart Failure, vol. 25, no. 8, 2023, https://doi.org/10.1002/ejhf.2922.